Clinical Trial Update: Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients [Phase 4]

View source ↗

Summary

Phase IV clinical trial to evaluate the efficacy and safety of extending high-dose ribavirin therapy in patients co-infected with chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Hospital Carlos III, Madrid | Conditions: Chronic Hepatitis C | Phase 4 | Status: UNKNOWN